Hide filtersShow filters × Close Bryan, Garnier & Co successfully leads a €40 million private placement in public equity for BioAlliance Bryan, Garnier & Co successfully leads a €100.1 million capital increase for Transgene Bryan, Garnier & Co successfully leads the secondary placement of 20.5% of NetBooster shares Bryan, Garnier & Co successfully advises AS INFOR’s shareholders on the sale of the company to CEGID Group Bryan, Garnier & Co leads €45 million secondary placement of Parrot shares on Euronext Bryan, Garnier & Co successfully advised Influe shareholders in their merger with Generix Bryan, Garnier & Co successfully leads a €66.1 million capital increase for Sword Group Bryan Garnier & Co leads €15 million IPO of the first internet up-market wines retailer on Alternext, Euronext’s alternative investment market Bryan, Garnier & Co successfully leads a €33.7 million IPO for Innate Pharma Bryan Garnier & Co successfully leads a EUR 19.1 million follow-on offering for Risc Group (Euronext: RSC) Bryan Garnier & Co successfully leads a EUR 3.8 million follow-on offering for Access Commerce (Euronext: CES), the leading Multi-channel Commerce solutions company Bryan, Garnier & Co successfully advised Divalto on the opening of its capital to Before, through an owner buy-out (OBO)
